Search

everythinglearnresearchcommunity

for

Search:↓

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

γδ T cells adapt uniquely to different tissues in mice.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

UV light helped human hair transplants survive in mice without broad immunosuppression.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.